These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 9396991)

  • 1. A simple index to predict prognosis independent of axillary node information in breast cancer.
    Seshadri R; Horsfall DJ; McCaul K; Leong AS
    Aust N Z J Surg; 1997 Nov; 67(11):765-70. PubMed ID: 9396991
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relationship between p53 gene abnormalities and other tumour characteristics in breast-cancer prognosis.
    Seshadri R; Leong AS; McCaul K; Firgaira FA; Setlur V; Horsfall DJ
    Int J Cancer; 1996 Apr; 69(2):135-41. PubMed ID: 8608982
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A simple index using video image analysis to predict disease outcome in primary breast cancer.
    Lockwood CA; Ricciardelli C; Raymond WA; Seshadri R; McCaul K; Horsfall DJ
    Int J Cancer; 1999 Jun; 84(3):203-8. PubMed ID: 10371334
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predictors of axillary lymph node metastases in patients with invasive breast carcinoma by a combination of classical and biological prognostic factors.
    González-Vela MC; Garijo MF; Fernández FA; Buelta L; Val-Bernal JF
    Pathol Res Pract; 1999; 195(9):611-8. PubMed ID: 10507081
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Clinicopathological features and prognostic factors of breast cancer patients with inguinal lymph node metastases: a report of 17 cases].
    Li Q; Xu BH; Zhang P; Li Q; Yuan P; Wang JY; Luo Y; Ma F; Fan Y; Li Q
    Zhonghua Zhong Liu Za Zhi; 2013 Mar; 35(3):207-11. PubMed ID: 23880002
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Traditional and new prognosticators in breast cancer: Nottingham index, Mib-1 and estrogen receptor signaling remain the best predictors of relapse and survival in a series of 289 cases.
    Megha T; Neri A; Malagnino V; Caruso S; Onorati M; Roviello F; Tosi P
    Cancer Biol Ther; 2010 Feb; 9(4):266-73. PubMed ID: 20026902
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Lobular invasive breast cancer prognostic factors: About 940 patients].
    Jauffret C; Houvenaeghel G; Classe JM; Garbay JR; Giard S; Charitansky H; Cohen M; Bélichard C; Faure C; Darai É; Hudry D; Azuar P; Villet R; Gimbergues P; Tunon de Lara C; Martino M; Coutant C; Dravet F; Chauvet MP; Chéreau Ewald E; Penault-Llorca F; Goncalves A; Lambaudie É
    Gynecol Obstet Fertil; 2015 Nov; 43(11):712-7. PubMed ID: 26482833
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [A new perspective on axillary dissection in situations of metastatic sentinel node].
    Zedníková I; Ňaršanská A; Hes O; Metelková A; Fiala O; Svoboda T
    Rozhl Chir; 2017; 96(8):346-352. PubMed ID: 29058925
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Correlation Between Raf/MEK/ERK Signaling Pathway and Clinicopathological Features and Prognosis for Patients With Breast Cancer Having Axillary Lymph Node Metastasis.
    Shao GL; Wang MC; Fan XL; Zhong L; Ji SF; Sang G; Wang S
    Technol Cancer Res Treat; 2018 Jan; 17():1533034617754024. PubMed ID: 29529946
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Survival impact and predictive factors of axillary recurrence after sentinel biopsy.
    Houvenaeghel G; Classe JM; Garbay JR; Giard S; Cohen M; Faure C; Charytansky H; Rouzier R; Daraï E; Hudry D; Azuar P; Villet R; Gimbergues P; Tunon de Lara C; Martino M; Fraisse J; Dravet F; Chauvet MP; Goncalves A; Lambaudie E
    Eur J Cancer; 2016 May; 58():73-82. PubMed ID: 26971077
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Morphometry and breast cancer. II. Characterisation of breast cancer cells with high malignant potential in patients with spread to lymph nodes: preliminary results.
    van der Linden HC; Baak JP; Lindeman J; Hermans J; Meyer CJ
    J Clin Pathol; 1986 Jun; 39(6):603-9. PubMed ID: 3722413
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment results and prognostic factors of early breast cancer treated with a breast conserving operation and radiotherapy.
    Kim KJ; Huh SJ; Yang JH; Park W; Nam SJ; Kim JH; Lee JH; Kang SS; Lee JE; Kang MK; Park YJ; Nam HR
    Jpn J Clin Oncol; 2005 Mar; 35(3):126-33. PubMed ID: 15741302
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Patients with recurrent breast cancer: does the primary axillary lymph node status predict more aggressive tumor progression?
    Rack B; Janni W; Gerber B; Strobl B; Schindlbeck C; Klanner E; Rammel G; Sommer H; Dimpfl T; Friese K
    Breast Cancer Res Treat; 2003 Nov; 82(2):83-92. PubMed ID: 14692652
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term prognoses and outcomes of axillary lymph node recurrence in 2,578 sentinel lymph node-negative patients for whom axillary lymph node dissection was omitted: results from one Japanese hospital.
    Ogiya A; Kimura K; Nakashima E; Sakai T; Miyagi Y; Iijima K; Morizono H; Makita M; Horii R; Akiyama F; Iwase T
    Breast Cancer; 2016 Mar; 23(2):318-22. PubMed ID: 25376341
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mib-1 proliferation index is an independent predictor of lymph node metastasis in invasive breast cancer: a prospective study on 675 patients.
    Marrelli D; Pinto E; Neri A; Megha T; Gioffrè W; Cioppa T; De Marco G; De Stefano A; Roviello F
    Oncol Rep; 2006 Feb; 15(2):425-9. PubMed ID: 16391864
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A simple index to predict prognosis independent of axillary node information in breast cancer: comment.
    Willsher PC; Metcalf C
    Aust N Z J Surg; 1998 Jun; 68(6):456-7. PubMed ID: 9623468
    [No Abstract]   [Full Text] [Related]  

  • 17. Association between axillary lymph node status and Ki67 labeling index in triple-negative medullary breast carcinoma.
    Chu Z; Lin H; Liang X; Huang R; Tang J; Bao Y; Jiang J; Zhan Q; Zhou X
    Jpn J Clin Oncol; 2015 Jul; 45(7):637-41. PubMed ID: 25862826
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Absent progesterone receptor expression in the lymph node metastases of ER-positive, HER2-negative breast cancer is associated with relapse on tamoxifen.
    Snell CE; Gough M; Middleton K; Hsieh M; Furnas L; Seidl B; Gibbons K; Pyke C; Shannon C; Woodward N; Armes JE
    J Clin Pathol; 2017 Nov; 70(11):954-960. PubMed ID: 28416639
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identifying good prognosis group of breast cancer patients with 1-3 positive axillary nodes for adjuvant cyclophosphamide, methotrexate and 5-fluorouracil (CMF) chemotherapy.
    Lin YC; Chen SC; Chang HK; Hsueh S; Tsai CS; Lo YF; Hwang TL; Chen MF
    Jpn J Clin Oncol; 2005 Sep; 35(9):514-9. PubMed ID: 16199422
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Effect of the proliferation rate on the course of node negative breast carcinoma].
    Mitze M; Weikel W; Brumm C; Lippold R; Knapstein PG
    Geburtshilfe Frauenheilkd; 1995 Jun; 55(6):299-305. PubMed ID: 7657137
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.